Hemrajani Rekha

Director at LB PHARMACEUTICALS INC · on record since Jun 5, 2026
Director at BioAge Labs, Inc. · on record since Jun 12, 2026
See Remarks at Arcus Biosciences, Inc. · on record since Mar 25, 2019
Director at Adverum Biotechnologies, Inc. · on record since May 3, 2019
Director at Aravive, Inc. · on record since Jan 9, 2020
President and CEO at Aravive, Inc. · on record since Jan 9, 2020
See Remarks at Aravive, Inc. · on record since Apr 9, 2020
Director at ALX ONCOLOGY HOLDINGS INC · on record since Jul 21, 2020
Director at Jiya Acquisition Corp. · on record since Nov 18, 2020
Chief Executive Officer at Jiya Acquisition Corp. · on record since Nov 18, 2020
Director at MAXCYTE, INC. · on record since Jul 29, 2021

Insider trading activity of Hemrajani Rekha

Transactions on record: 34; since Mar 25, 2019

Open-market buys: 3; $157.5K

Open-market sells: 1; $22.3K

Companies traded: 7; last filing Jun 22, 2026

Figures computed from official regulatory filings — .

Companies where Hemrajani Rekha has traded

MAXCYTE, INC.11 tx · $22.3K · Jun 22, 2026
BioAge Labs, Inc.5 tx · $54K · Jun 12, 2026
LB PHARMACEUTICALS INC2 tx · Jun 5, 2026
ALX ONCOLOGY HOLDINGS INC8 tx · $103.5K · Jan 21, 2026
Adverum Biotechnologies, Inc.4 tx · Jun 25, 2020
3 tx · Apr 9, 2020
1 tx · Mar 25, 2019

Track record of Hemrajani Rekha

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Hemrajani Rekha

Co-insiders of Hemrajani Rekha

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
MAXCYTE, INC.Listing on record	Jun 22, 2026	AwardD (derivative)	49,579	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Jun 22, 2026	Award	30,421	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Jun 12, 2026	AwardD (derivative)	22,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LB PHARMACEUTICALS INCListing unverified	Jun 5, 2026	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Jan 21, 2026	AwardD (derivative)	40,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LB PHARMACEUTICALS INCListing unverified	Sep 12, 2025	AwardD (derivative)	22,449	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Aug 27, 2025	Sell	-10,684	2.09 USD	$22.3K		SEC
MAXCYTE, INC.Listing on record	Jun 23, 2025	Award	29,210	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Jun 23, 2025	AwardD (derivative)	50,790	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Jun 9, 2025	AwardD (derivative)	22,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Mar 10, 2025	Buy	3,000	18.00 USD	$54K	conv 75ClusterFirst in 12mo	SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Jan 23, 2025	AwardD (derivative)	40,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Dec 4, 2024	Buy	30,000	1.55 USD	$46.5K	conv 76	SEC
BioAge Labs, Inc.Listing on record	Sep 27, 2024	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Sep 27, 2024	AwardD (derivative)	28,497	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Jun 14, 2024	AwardD (derivative)	20,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Jun 13, 2024	Award	21,367	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Jun 13, 2024	AwardD (derivative)	40,701	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Jun 23, 2023	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Jun 22, 2023	AwardD (derivative)	20,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Mar 21, 2023	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Jul 8, 2022	AwardD (derivative)	26,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Jun 16, 2022	AwardD (derivative)	12,004	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Aug 11, 2021	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Jun 15, 2021	AwardD (derivative)	12,004	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
MAXCYTE, INC.Listing on record	Jun 22, 2026	AwardD (derivative)	49,579	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Jun 22, 2026	Award	30,421	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Jun 12, 2026	AwardD (derivative)	22,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LB PHARMACEUTICALS INCListing unverified	Jun 5, 2026	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Jan 21, 2026	AwardD (derivative)	40,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LB PHARMACEUTICALS INCListing unverified	Sep 12, 2025	AwardD (derivative)	22,449	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Aug 27, 2025	Sell	-10,684	2.09 USD	$22.3K		SEC
MAXCYTE, INC.Listing on record	Jun 23, 2025	Award	29,210	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Jun 23, 2025	AwardD (derivative)	50,790	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Jun 9, 2025	AwardD (derivative)	22,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Mar 10, 2025	Buy	3,000	18.00 USD	$54K	conv 75ClusterFirst in 12mo	SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Jan 23, 2025	AwardD (derivative)	40,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Dec 4, 2024	Buy	30,000	1.55 USD	$46.5K	conv 76	SEC
BioAge Labs, Inc.Listing on record	Sep 27, 2024	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BioAge Labs, Inc.Listing on record	Sep 27, 2024	AwardD (derivative)	28,497	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Jun 14, 2024	AwardD (derivative)	20,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Jun 13, 2024	Award	21,367	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Jun 13, 2024	AwardD (derivative)	40,701	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Jun 23, 2023	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Jun 22, 2023	AwardD (derivative)	20,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Mar 21, 2023	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Jul 8, 2022	AwardD (derivative)	26,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Jun 16, 2022	AwardD (derivative)	12,004	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MAXCYTE, INC.Listing on record	Aug 11, 2021	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALX ONCOLOGY HOLDINGS INCListing on record	Jun 15, 2021	AwardD (derivative)	12,004	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC